NovaBay Pharmaceuticals, Inc. earnings per share and revenue

NBY earnings per share for the last quarter are -1.37 USD whereas the estimation was -1.23 USD which accounts for -11.84% surprise. Company revenue for the same period amounts to 2.40 M USD despite the estimated figure of 2.40 M USD. Estimated earnings per share for the next quarter are -0.30 USD, and revenue is expected to reach 2.60 M USD. Also watch annual changes over time to get a bigger picture of NBY earnings per share and revenue dynamics.